Results 121 to 130 of about 146,300 (194)

Luteolin mitigates proliferative vitreoretinopathy through inhibition of ERK1/2 signaling and epithelial-mesenchymal transition. [PDF]

Front Pharmacol
Wu L, Chen M, Chai J, Tang Y, Xu Q.
europepmc   +1 more source

Sustained closure of surgically repaired macular hole after proliferative vitreoretinopathy

Indian Journal of Ophthalmology, 2008
Mitamura Yoshinori, Yamamoto Shuichi
doaj  

Drug strategies for the treatment and prevention of proliferative vitreoretinopathy: an overview of innovative treatment concepts. [PDF]

Int Ophthalmol
Luyken AK, Junge V, Schulz A, Fuchsluger TA, Schaub F.   +4 more
europepmc   +1 more source

The Effect of Statins on the Prevention of Proliferative Vitreoretinopathy (PVR) Following Vitrectomy or Scleral Buckling for Rhegmatogenous Retinal Detachment (RRD): A Pilot Randomized Controlled Trial. [PDF]

Clin Ophthalmol
Gordiz A, Sardarinia M, Zare Hosseinabadi V, Zahmatkesh MM, Zarastvand F, Rahimnezhad N, Chaibakhsh S, Ramezanlou M, Hemmati S, Hoveidamanesh S, Abdi F.   +10 more
europepmc   +1 more source

MIF inhibition attenuates proliferative vitreoretinopathy pathogenesis and protects the eye in preclinical model. [PDF]

Biomed Pharmacother
Hamadmad S, Heisler-Taylor T, Summitt D, Shalash R, Zatari A, Martini D, Sohail M, Racine J, Xie Z, Hill K, Phelps M, Cebulla CM.   +11 more
europepmc   +1 more source

Pathogenic mechanisms and treatment advances in proliferative vitreoretinopathy: A review. [PDF]

Medicine (Baltimore)
Dai J, Zhou X, Bai H, Zeng M, Peng Q, Wu Q.   +5 more
europepmc   +1 more source

LARGE-SIZED HUMAN AMNIOTIC MEMBRANE PATCHING-ASSISTED VITRECTOMY FOR THE MANAGEMENT OF POSTOPERATIVE PROLIFERATIVE VITREORETINOPATHY IN COMPLEX RHEGMATOGENOUS RETINAL DETACHMENTS. [PDF]

Retina
Gu R, Wu K, Zhang W, Jiang R, Xu G, Sun Z.   +5 more
europepmc   +1 more source

Effect of 3',4'-Dihydroxyflavonol Eye Drops in a Rat Model of Dispase-Induced Proliferative Vitreoretinopathy. [PDF]

Antioxidants (Basel)
Chan EC, Zeng C, Luu CD, Abbott CJ, Chan NT, Datta KK, Williamson N, Allen PJ, Fan Gaskin JC.   +8 more
europepmc   +1 more source

Long-Term Cannabis Use and Risk of Postoperative Proliferative Vitreoretinopathy. [PDF]

JAMA Ophthalmol
Alshaikhsalama AM, Alsoudi AF, Mukhtar A, Wai K, Koo E, Kossler A, Ludwig C, Mruthyunjaya P, Rahimy E.   +8 more
europepmc   +1 more source

From fibrotic mechanisms to clinical translation: the drug therapy revolution and delivery system breakthrough in proliferative vitreoretinopathy. [PDF]

Front Immunol
Chen Z, Liu J, Quan L, Wu L, Xu Q.
europepmc   +1 more source